Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus

Analytical and Quantitative Cytology and Histology

Volumn 19, Issue 3, 1997, Pages 246-254

  Polkowski, Wojciech ^a   Meijer, Gerrit A ^b   Baak, Jan P A ^b   Ten Kate, Febo J W ^c   Obertop, Hugo ^c   Offerhaus, G Johan A ^c   Van Lanschot, Jan J B ^c  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Barrett esophagus; Image cytometry; Immunohistochemistry; Ki 67; P53; Quantitative pathology

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; ESOPHAGUS MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ASSAY; REPRODUCIBILITY; SAMPLING;

BARRETT ESOPHAGUS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030925250     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Altorki NK, Sunagawa M, Little AG, Skinner DB: High-grade dysplasia in columnar-lined esophagus. Am J Surg 1991;161:97-99
2. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR: An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12
3. Blount PL, Ramel S, Raskind WH, Haggitt RC, Sanchez CA, Dean PJ, Rabinovitch PS, Reid BJ: 17p Allelic deletions and p53 overexpression in Barrett's adenocarcinoma. Cancer Res 1991;51:5482-5486
4. Brugghe J, Baak JPA, Meijer GA: Volume percentage of epithelium in ovarian tumours: A methodological study (abstr). Proc of the Pathological Society of Great Britain and Ireland, Amsterdam, 1995
5. Fleege JC, Diest PJ van, Baak JPA: Analysis of measuring system parameters that influence reproducibility of morphometric assessments with a graphic tablet. Hum Pathol 1988;19: 513-517
6. Fleege JC, Diest PJ van, Baak JPA: Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest 1990;63: 270-275
7. Fleege JC, Diest PJ van, Baak JPA: Refinement and multi-ob-server evaluation of systematic random sampling to improve reproducibility in interactive nuclear morphometry. Analyt Quant Cytol Histol 1993;15:281-289
8. Gillen P, McDermott M, Grehan D, O'B Hourikane D, Hennessy TPJ: Proliferating cell nuclear antigen in the assessment of Barrett's mucosa. Br J Surg 1994;81:1766-1768
9. Gray MR, Hall PA, Nash J, Ansari B, Lane DP, Kingsnorth AN: Epithelial proliferation in Barrett's oesophagus by proliferating cell nuclear antigen immunolocalisation. Gastroenterology 1992;103:1769-1776
10. Gundersen HJG, Jensen EB: The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987; 147:229-263
11. Hamilton SR: Adenocarcinoma in Barrett's oesophagus. In Gastrointestinal and Oesophageal Pathology. Edited by R Whitehead. Edinburgh, Churchill Livingstone, 1989, pp 683-700
12. Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, Allegra CJ, Johnston PG: Expansion of the Ki67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75:423-429
13. Iftikhar SY, Steele RJC, Watson S, James PD, Dilks K, Hardcastle JD: Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's esophagus. Gut 1992;33:733-737
14. Makkink-Nombardo SV, Baak JPA, Schuurmans L, Theeuwes JW, Aa van der T: Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: A reproducibility study. Anal Cell Pathol 1995;8:227-245
15. Oort J, Baak JPA: Structural morphology and the need for selection in quantitative pathology. In Manual of Quantitative Pathology in Cancer Diagnosis and Prognosis. Edited by JPA Baak. Berlin, Springer-Verlag, 1991, pp 28-32
16. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC: Barrett's oesophagus with high-grade dysplasia: An indication for esophagectomy? Ann Thorac Surg 1992;54:199-204
17. Polkowski W, Lanschot JJB van, Kate FJW ten, Baak JPA, Tytgat GNJ, Obertop H, Voorn WJ, Offerhaus GJA: The value of p53 and Ki67 as markers for tumour progression in the Barrett's dysplasia-carcinoma sequence. Surg Oncol 1995;4:163-171
18. Ramel S, Reid BJ, Sanchez CA, Blount PL, Levine DS, Neshat K, Haggitt RC, Dean PJ, Thor K, Rabinovitch PS: Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology 1992;102:1220-1228
19. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Belle van B, Lewin K, Weinstein WM, Antonioli DA, Goldman H, McDonald W, Owen D: Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Human Pathol 1988;19:166-178
20. Reid BJ, Sanchez CA, Blount PL, Levine DS: Barrett's esophagus: Cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-129
21. Rice TW, Falk GW, Achkar E, Petras RE: Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-1836
22. Rose DSC, Maddox PH, Brown DC: Which proliferation markers for routine immunohistology?: A comparison of five antibodies. J Clin Pathol 1994;47:1010-1014